Authors: | Cardoso, F.; Costa, A.; Norton, L.; Senkus, E.; Aapro, M.; André, F.; Barrios, C. H.; Bergh, J.; Biganzoli, L.; Blackwell, K. L.; Cardoso, M. J.; Cufer, T.; El Saghir, N.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K.; Giordano, S. H.; Gligorov, J.; Goldhirsch, A.; Harbeck, N.; Houssami, N.; Hudis, C.; Kaufman, B.; Krop, I.; Kyriakides, S.; Lin, U. N.; Mayer, M.; Merjaver, S. D.; Nordström, E. B.; Pagani, O.; Partridge, A.; Penault-Llorca, F.; Piccart, M. J.; Rugo, H.; Sledge, G.; Thomssen, C.; van't Veer, L.; Vorobiof, D.; Vrieling, C.; West, N.; Xu, B.; Winer, E. |
Article Title: | ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) |
Keywords: | cancer survival; overall survival; drug efficacy; bone metastasis; capecitabine; paclitaxel; cancer staging; outcome assessment; cancer grading; evidence based medicine; cancer palliative therapy; carboplatin; progression free survival; quality of life; breast cancer; epidermal growth factor receptor 2; aromatase inhibitor; practice guideline; cancer resistance; docetaxel; liver metastasis; cancer regression; brain metastasis; tamoxifen; psychosocial care; consensus development; inoperable cancer; taxane derivative; cancer classification; cancer control; anthracycline derivative; trastuzumab; everolimus; lapatinib; chemoradiotherapy; pertuzumab; randomized controlled trial (topic); clinical trial (topic); phase 2 clinical trial (topic); triple negative breast cancer; inflammatory breast cancer; trastuzumab emtansine; human; article |
Journal Title: | Breast |
Volume: | 23 |
Issue: | 5 |
ISSN: | 0960-9776 |
Publisher: | Elsevier Inc. |
Date Published: | 2014-10-01 |
Start Page: | 489 |
End Page: | 502 |
Language: | English |
DOI: | 10.1016/j.breast.2014.08.009 |
PROVIDER: | scopus |
PUBMED: | 25244983 |
DOI/URL: | |
Notes: | Export Date: 1 December 2014 -- Source: Scopus |